New Delhi: CEO of Serum Institute of India, Adar Poonawala has announced to reduce the price of Covishield from Rs 400 to Rs 300 per dose for the state governments. Let us know that earlier the Center had asked SII and Bharat Biotech to reduce the price of their Covid-19 vaccines. This step assumes great importance before the new phase of vaccination, which begins on May 1, will allow all people over the age of 18 to be vaccinated. Many opposition parties like the Congress had demanded a uniform price for the state governments and the Center.
Announcing this on Twitter, Poonawala said that ‘this will save the financial resources of thousands of crores of state governments’. In addition, he said that ‘it will help speed up the vaccination campaign and save countless lives’.
Explain that while the purchase price of the centre is Rs 150 per dose for both Covishield and Covaxin, state governments and private hospitals have to buy them at a higher price. For example, Bharat Biotech has offered the vaccine at Rs 600 per dose to state governments and Rs 1200 per dose to private hospitals.
Centre changes the vaccination policy
In addition to Covishield and Covaxin, DCGI has also approved Sputnik V on 12 April, accepting the recommendations of the Subject Expert Committee of the Central Drugs Standard Control Organization. In addition, the Center stated that a vaccine approved for restricted use by the USFDA, EMA, UK MHRA, PMDA Japan, or listed in the WHO (Emergency Use Listing), would be approved for emergency use in India.
The same centre, making a major announcement on 19 April, has started vaccinations for people above 18 from 1 May. Also said that vaccine manufacturers can supply 50 per cent of their doses to state governments and the open market. Private hospitals will have to supply vaccine from this quota.
With this, the Government of India will continue to have vaccinations at the vaccination centres for health and frontline workers and those above 45 years of age. In addition, the Center said it would allocate vaccine doses to states with the remaining 50% quota based on factors such as the number of active cases, speed of vaccination, and vaccine wastage. A total of 14,78,27,367 persons have been vaccinated in India so far.